COVID-19 pandemic reversed years of progress against antimicrobial resistance

The COVID-19 pandemic reversed years of progress against antimicrobial resistance in the United States, with resistant hospital-onset infections and deaths both increasing at least 15% during the first year, according to a new CDC report.
“This setback can and must be temporary,” Michael Craig, MPP, director of the CDC’s Antibiotic Resistance Coordination & Strategy Unit, said in a press release. “The COVID-19 pandemic has unmistakably shown us that antimicrobial resistance will not stop if we let down our guard; there is no time to waste.”
According to the

The COVID-19 pandemic reversed years of progress against antimicrobial resistance in the United States, with resistant hospital-onset infections and deaths both increasing at least 15% during the first year, according to a new CDC report.
“This setback can and must be temporary,” Michael Craig, MPP, director of the CDC’s Antibiotic Resistance Coordination & Strategy Unit, said in a press release. “The COVID-19 pandemic has unmistakably shown us that antimicrobial resistance will not stop if we let down our guard; there is no time to waste.”
According to the